EndoRobotics | Endoscopic Robot Manufacturer & ESD Solutions

EndoRobotics | Endoscopic Robot Manufacturer & ESD Solutions

9

Company Profile

EndoRobotics is a South Korea-based manufacturer of    endoscopic robotic systems, headquartered in    Seoul, South Korea. Founded in    2019, the company operates as an independent private entity with    46 employees, serving global gastroenterology markets through an exclusive distribution partnership with    Olympus Corporation.

Core Products & Technologies

Robotic Endoscopy Systems

ROBOPERA System (ER-R-002 / ER-R-003): FDA-cleared robotic console and accessories for therapeutic endoscopy, approved September 24, 2025
   • Articulated Grippers: Precision robotic graspers for tissue manipulation during complex endoscopic procedures
   • Scope-Mounted Traction Device: Robotic-assisted traction system for endoscopic submucosal dissection (ESD)

Training & Simulation

EndoCubot ESD Simulator: Robotic training platform and accessories for ESD procedure simulation and clinician education

Market Position & Certifications

EndoRobotics holds an emerging leadership position in the global therapeutic endoscopy robotics market,    competing with EndoQuest Robotics and    Intuitive Surgical. Key strengths include:

7 years of Korean engineering heritage in endoscopic robotics
   • $35.1M total funding raised across multiple venture rounds
   • Regulatory compliance: FDA 510(k) cleared (K244029, September 24, 2025)
   • Global distribution: Exclusive worldwide partnership with Olympus Corporation, launching initially in the U.S.

Corporate Timeline

2019 — Founded in Seoul, South Korea
   2021 — Completed Series A funding
   2023 — Secured Series B investment
   2025 — Received FDA 510(k) clearance for ROBOPERA system (K244029); completed Series C ($22.3M)
   2026 — Signed exclusive global distribution agreement with Olympus Corporation (May 4, 2026)

Target Markets & Applications

Endoscopic Submucosal Dissection (ESD): ROBOPERA system, articulated grippers, and traction devices for organ-sparing lesion removal
   • Early-Stage GI Cancer Treatment: Robot-assisted removal of gastric and colorectal neoplasia
   • Therapeutic Endoscopy Training: EndoCubot simulator for ESD procedure education and skill development

Contact Information

Global Headquarters

Address: 14-15 Floor, 57 Deahk-ro, Jongno-gu, Seoul 03082, South Korea
   Telephone: +82-70-4129-9634

Corporate Status

Entity Type: Independent Private Company (No Parent Company)
   Stock: Not Publicly Traded
   Website: endorobo.com

文章下方广告位

网友评论

访客信息

你已经3分钟没有访问该网站

这些可能是你需要的内容: